Found vs Enhance MD: Personalized Plans vs Flat-Rate Compounds
Found vs Enhance MD compares two telehealth weight-loss platforms with different approaches: Found emphasizes a biology-first, personalized medically supervised program with plans starting at $39, while Enhance MD highlights low first-month compound pricing and flat-rate pricing, with semaglutide from $49 first month. Early verdict: choose Found if you want a biology-centered program that accepts most insurance; choose Enhance MD if you prioritize the lowest first-month compound price and consistent flat-rate fees.
Explore Found plans starting at $39
Found vs Enhance MD: key differences at a glance
This comparison highlights the most distinctive differences supported by the source evidence: pricing structure and introductory rates, insurance acceptance and billing model, personalization and program focus, medications offered and compound status, and regulatory disclaimers.
1. Pricing model and introductory pricing
Enhance MD advertises semaglutide from $49 and tirzepatide from $99 for the first month, and emphasizes flat-rate pricing that stays the same at every dose with no fee escalation. Enhance MD positions those as the cheapest first-month prices for compounds.
Found markets “get started for as low as $39” and describes affordable monthly plans and flexible pricing. Found also lists specific membership starting figures across different presentations and advertises offers tied to commitments in some landing-page evidence.
See Enhance MD semaglutide from $49 first month
2. Insurance acceptance and billing model
Found states “Most insurance now accepted” and says it handles insurance paperwork, including notes about Medicare GLP-1 Bridge Program options and specific copay examples. Found claims it is the only telehealth provider that allows use of insurance benefits to save on compounded GLP-1s for some Americans, and that medication coverage and copays vary by eligibility and insurance approval.
Enhance MD operates on a direct-pay model and does not bill insurance, according to the source evidence. The absence of insurance billing is presented as a tradeoff that enables low first-month pricing and flat-rate ongoing costs.
3. Personalization and program focus
Found emphasizes a biology-first approach: a personalized medically supervised weight loss program tailored to metabolic biology, hormones, blood sugar regulation, sleep, and behavioral factors. Found frames itself as building individualized programs rather than prescribing one medication protocol for all patients.
Enhance MD emphasizes clinician-directed compounds and metabolic lab testing every six months in its landing evidence, and presents its value as premium metabolic care coupled with transparent flat-rate pricing for compound GLP-1s. The source does not provide a detailed comparison of Found-style biology-first workflows for Enhance MD.
4. Medications offered, branded vs compounded
Both providers offer semaglutide and tirzepatide in some form according to the source content. Found lists tirzepatide and semaglutide and references branded options like Zepbound and Wegovy in promotional text, while also noting compounded options. Enhance MD offers compounded semaglutide and tirzepatide and highlights availability of both compounds on one platform.
Found includes marketing text referencing brand-name GLP-1s availability through insurance and specific program offers, but also contains an explicit IMPORTANT note: certain medications are FDA-approved for conditions other than weight and Found is not affiliated with or endorsed by trademark owners. Enhance MD states its compounds are clinician-directed and compounded, not branded finished products.
5. Regulatory and safety disclaimers
Both sources include the regulatory qualifier that compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. Found repeats that compounded GLP-1s are not FDA-approved or evaluated for safety or efficacy and may not be available in all states. Enhance MD also states that compounded medications, when offered, are not FDA-approved finished products.
| Criteria | Found | Enhance MD |
|---|---|---|
| Starting price | Get started for as low as $39 | Semaglutide from $49 first month; tirzepatide from $99 first month |
| Pricing model | Affordable monthly plans, flexible pricing, some offers tied to commitments | Flat-rate pricing: same price at every dose after intro; no fee escalation |
| Insurance | Most insurance now accepted; Found handles insurance paperwork | Direct-pay only; does not bill insurance |
| Medications | Semaglutide, tirzepatide; mentions branded and compounded options | Compounded semaglutide and tirzepatide available on one platform |
| Regulatory note | Compounded medications are not FDA-approved | Compounded medications are not FDA-approved |
Start Found’s biology-first intake
How to decide between Found and Enhance MD
If you need insurance billing, potential access to brand-name GLP-1s through coverage, or a program explicitly built around metabolic biology and lifestyle factors, Found is the option the sources describe as focused on personalization and insurance support. If your priority is the lowest first-month compound price for semaglutide or tirzepatide and predictable flat-rate pricing that does not increase with dose, the source evidence points to Enhance MD.
Check Enhance MD flat-rate compound pricing
Final take: Found vs Enhance MD
Found vs Enhance MD boils down to personalization plus insurance support versus introductory compound pricing and flat-rate billing. Both providers offer semaglutide and tirzepatide in compound form and both include regulatory notes that compounded medications are not FDA-approved.
Choose Found if you want a biology-first, personalized medically supervised program that accepts most insurance and can handle insurance paperwork. Choose Enhance MD if you want semaglutide from $49 first month or tirzepatide from $99 first month and a flat-rate pricing model with the same price at every dose.